14
May 2026
Regular arts and physical activity linked to slower aging
Research shows that leisure activities, including arts engagement and physical exercise, are linked to slower epigenetic aging and improved health outcomes.
Stay Informed!
14
May 2026
Four-week diet intervention shifts biological aging markers
A short-term shift to whole-food, plant-based diets alters aging biomarkers in older adults, suggesting rapid physiological adaptation rather than age reversal.
14
May 2026
Colbopasvir plus sofosbuvir achieves high cure rates in chronic hepatitis C
In this real‑world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received colbopasvir (60 mg) + sofosbuvir (400 mg) daily for 12 weeks. Overall SVR12 was 99.1% (112/113). SVR12 was 100% for genotypes 3a, 3b, 6a, and compensated cirrhosis, 93.3% for genotype 1b, and 90% for HBV co‑infection.
14
May 2026
Art history may help doctors better understand obesity stigma
Understanding how obesity has been portrayed in art across the ages can make doctors more empathic and less judgmental, which should lead to their patients achieving better outcomes, new reasearch at this year's European Congress on Obesity (ECO 2026) argues.
14
May 2026
New standards improve quality of donated prosthetic feet worldwide
Researchers have proposed new standards into the decades' old prosthetic donations market, improving the quality of lower limb prosthetic feet by two-thirds – a major quality of life boost for recipients.
13
May 2026
Four OICR-funded studies explore transformative approaches in cancer care
Four new research studies funded by the Ontario Institute for Cancer Research (OICR) will deliver cutting-edge innovations by maximizing the impact of existing research and making the most out of patient contributions.
13
May 2026
Sequential TACE after SBRT improves outcomes in recurrent hepatocellular carcinoma
Comparative data on sequential transarterial chemoembolization (TACE) after stereotactic body radiation therapy (SBRT) in recurrent hepatocellular carcinoma (HCC) remain limited. This study aimed to evaluate the efficacy of this combination.
13
May 2026
Qureight to support Mediar Therapeutics' Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis
Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, and Mediar Therapeutics (Mediar), a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced Qureight's AI-powered 3D quantitative imaging analytics platform and services will be used to support Mediar's Phase 2 EncompaSSc clinical trial.
13
May 2026
Base editing approach repairs deadly Dravet syndrome mutation in mice
Gene editing can repair a DNA error in mice that causes Dravet syndrome, a rare, incurable, and potentially deadly form of childhood epilepsy. After the edit, the mice have far fewer seizures and live much longer.
13
May 2026
Wearable wireless polygraph tracks hidden stress signals
Northwestern University engineers have developed a small, wireless polygraph system you can wear.
